Symbols / HLN Stock $9.33 -0.59% Haleon plc

Healthcare • Drug Manufacturers - Specialty & Generic • United Kingdom • NYQ
HLN (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Mr. Brian James McNamara
Exch · Country NYQ · United Kingdom
Market Cap 41.45B
Enterprise Value 90.90B
Income 1.67B
Sales 11.03B
FCF (ttm) 1.40B
Book/sh 5.01
Cash/sh 0.15
Employees 24,535
Insider 10d —
IPO Jul 25, 2022
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 37.08%
P/E 18.65
Forward P/E 15.28
PEG 2.44
P/S 3.76
P/B 1.86
P/C —
EV/EBITDA 33.14
EV/Sales 8.24
Quick Ratio 0.68
Current Ratio 0.92
Debt/Eq 52.37
LT Debt/Eq —
EPS (ttm) 0.50
EPS next Y 0.61
EPS Growth 92.00%
Revenue Growth 0.60%
EPS Gr Q/Q 86.40%
Rev Gr Q/Q —
Earnings (next) 2026-02-25
Earnings (prior) 2026-02-25
ROA 4.67%
ROE 10.27%
ROIC —
Gross Margin 64.77%
Oper. Margin 23.17%
Profit Margin 15.11%
Shs Outstand 4.44B
Shs Float 8.86B
Insider Own 0.01%
Instit Own 12.82%
Short Float 0.28%
Short Ratio 1.50
Short Interest 12.36M
52W High 11.42
vs 52W High -18.35%
52W Low 8.71
vs 52W Low 7.06%
Beta 0.25
Impl. Vol. 6.25%
Rel Volume 0.02
Avg Volume 8.24M
Volume 196.77K
Target (mean) $11.74
Tgt Median $11.85
Tgt Low $10.00
Tgt High $13.85
# Analysts 5
Recom Buy
Prev Close $9.38
Price $9.32
Change -0.59%
About

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Theraflu, and Flonase brands for respiratory issues; and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. Haleon plc was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. The company was founded in 1715 and is headquartered in Weybridge, the United Kingdom.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$11.74
Mean price target
2. Current target
$9.33
Latest analyst target
3. DCF / Fair value
$5.67
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$9.33
Low
$10.00
High
$13.85
Mean
$11.74

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-01-23 up Barclays Equal-Weight → Overweight —
2025-09-16 down Barclays Overweight → Equal-Weight —
2024-09-20 main Morgan Stanley Overweight → Overweight $11
2024-03-26 main Argus Research Buy → Buy $10
2023-11-01 init Morgan Stanley — → Overweight $9
2023-04-06 up Argus Research Hold → Buy $10
2022-09-28 init Argus Research — → Hold —
2022-07-29 init Deutsche Bank — → Hold —
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2025-09-23 McNamara (Brian) — — 2,027 $9.00 $18,243
2025-09-23 Wellington Management Group LLP — — 122,938 — —
2025-08-19 Wellington Management Group LLP — — 7,489 — —
2025-08-06 Wellington Management Group LLP — — 801,491 — —
2025-07-10 Wellington Management Group LLP — — 2,387,284 — —
2025-06-10 McNamara (Brian) — — 3,639 $10.87 $39,555
2025-03-19 Wellington Management Group LLP — — 56,333 — —
2025-03-14 Paley (Lisa) — — 289,881 — —
2025-03-14 Paley (Lisa) — — 135,511 $10.15 $1,375,436
2025-02-24 Pfizer Inc. — — 197,228,952 — —
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
11,030.00
-1.81%
11,233.00
-0.61%
11,302.00
+4.09%
10,858.00
Operating Revenue
11,030.00
-1.81%
11,233.00
-0.61%
11,302.00
+4.09%
10,858.00
Cost Of Revenue
3,950.00
-10.41%
4,409.00
-3.21%
4,555.00
+6.40%
4,281.00
Reconciled Cost Of Revenue
3,950.00
-10.41%
4,409.00
-3.21%
4,555.00
+6.40%
4,281.00
Gross Profit
7,080.00
+3.75%
6,824.00
+1.14%
6,747.00
+2.58%
6,577.00
Operating Expense
4,668.00
+1.08%
4,618.00
-2.80%
4,751.00
-0.02%
4,752.00
Research And Development
316.00
+6.04%
298.00
-4.18%
311.00
+3.67%
300.00
Selling General And Administration
4,364.00
-1.98%
4,452.00
+0.88%
4,413.00
-1.56%
4,483.00
General And Administrative Expense
4,364.00
-1.98%
4,452.00
+0.88%
4,413.00
-1.56%
4,483.00
Other Operating Expenses
-12.00
+90.91%
-132.00
-588.89%
27.00
+187.10%
-31.00
Total Expenses
8,618.00
-4.53%
9,027.00
-3.00%
9,306.00
+3.02%
9,033.00
Operating Income
2,412.00
+9.34%
2,206.00
+10.52%
1,996.00
+9.37%
1,825.00
Total Operating Income As Reported
2,412.00
+9.34%
2,206.00
+10.52%
1,996.00
+9.37%
1,825.00
EBITDA
2,859.00
+8.79%
2,628.00
+11.78%
2,351.00
+7.70%
2,183.00
Normalized EBITDA
2,814.00
+8.86%
2,585.00
+11.47%
2,319.00
+6.87%
2,170.00
Reconciled Depreciation
360.00
+11.11%
324.00
+4.85%
309.00
+7.67%
287.00
EBIT
2,499.00
+8.46%
2,304.00
+12.83%
2,042.00
+7.70%
1,896.00
Total Unusual Items
45.00
+4.65%
43.00
+34.38%
32.00
+146.15%
13.00
Total Unusual Items Excluding Goodwill
45.00
+4.65%
43.00
+34.38%
32.00
+146.15%
13.00
Special Income Charges
52.00
+842.86%
-7.00
-106.31%
111.00
+153.37%
-208.00
Other Special Charges
-52.00
-842.86%
7.00
+106.31%
-111.00
-153.37%
208.00
Net Income
1,667.00
+15.60%
1,442.00
+37.46%
1,049.00
-1.04%
1,060.00
Pretax Income
2,152.00
+12.67%
1,910.00
+17.32%
1,628.00
+0.62%
1,618.00
Net Non Operating Interest Income Expense
-305.00
+10.03%
-339.00
+15.25%
-400.00
-81.82%
-220.00
Interest Expense Non Operating
347.00
-11.93%
394.00
-4.83%
414.00
+48.92%
278.00
Net Interest Income
-305.00
+10.03%
-339.00
+15.25%
-400.00
-81.82%
-220.00
Interest Expense
347.00
-11.93%
394.00
-4.83%
414.00
+48.92%
278.00
Interest Income Non Operating
57.00
-12.31%
65.00
+160.00%
25.00
-59.68%
62.00
Interest Income
57.00
-12.31%
65.00
+160.00%
25.00
-59.68%
62.00
Tax Provision
472.00
+8.51%
435.00
-15.86%
517.00
+3.61%
499.00
Tax Rate For Calcs
0.00
-3.70%
0.00
-28.38%
0.00
+3.11%
0.00
Tax Effect Of Unusual Items
9.87
+0.78%
9.79
-3.76%
10.18
+153.81%
4.01
Net Income Including Noncontrolling Interests
1,680.00
+13.90%
1,475.00
+32.76%
1,111.00
-0.71%
1,119.00
Net Income From Continuing Operation Net Minority Interest
1,667.00
+15.60%
1,442.00
+37.46%
1,049.00
-1.04%
1,060.00
Net Income From Continuing And Discontinued Operation
1,667.00
+15.60%
1,442.00
+37.46%
1,049.00
-1.04%
1,060.00
Net Income Continuous Operations
1,680.00
+13.90%
1,475.00
+32.76%
1,111.00
-0.71%
1,119.00
Minority Interests
-13.00
+60.61%
-33.00
+46.77%
-62.00
-5.08%
-59.00
Normalized Income
1,631.87
+15.83%
1,408.79
+37.15%
1,027.18
-2.27%
1,051.01
Net Income Common Stockholders
1,667.00
+15.60%
1,442.00
+37.46%
1,049.00
-1.04%
1,060.00
Otherunder Preferred Stock Dividend
0.00
0.00
0.00
0.00
Diluted EPS
0.37
+17.83%
0.31
+38.94%
0.23
-1.74%
0.23
Basic EPS
0.37
+17.72%
0.32
+38.60%
0.23
-0.87%
0.23
Basic Average Shares
4,491.00
-1.58%
4,563.29
-0.82%
4,600.88
-0.36%
4,617.50
Diluted Average Shares
4,513.00
-1.73%
4,592.36
-1.06%
4,641.59
+0.52%
4,617.50
Diluted NI Availto Com Stockholders
1,667.00
+15.60%
1,442.00
+37.46%
1,049.00
-1.04%
1,060.00
Total Other Finance Cost
15.00
+50.00%
10.00
-9.09%
11.00
+175.00%
4.00
Line Item Trend 2025-12-31
Total Assets
32,630.00
Current Assets
4,550.00
Cash Cash Equivalents And Short Term Investments
1,260.00
Cash And Cash Equivalents
1,260.00
Cash Equivalents
—
Cash Financial
1,260.00
Other Short Term Investments
—
Receivables
—
Accounts Receivable
1,642.00
Gross Accounts Receivable
1,684.00
Allowance For Doubtful Accounts Receivable
-42.00
Other Receivables
287.00
Taxes Receivable
194.00
Accrued Interest Receivable
—
Loans Receivable
—
Inventory
1,025.00
Raw Materials
242.00
Work In Process
7.00
Finished Goods
776.00
Prepaid Assets
—
Restricted Cash
64.00
Assets Held For Sale Current
—
Hedging Assets Current
78.00
Total Non Current Assets
28,080.00
Net PPE
1,997.00
Gross PPE
3,561.00
Accumulated Depreciation
-1,564.00
Properties
0.00
Land And Improvements
1,044.00
Buildings And Improvements
100.00
Machinery Furniture Equipment
2,028.00
Construction In Progress
388.00
Other Properties
1.00
Goodwill And Other Intangible Assets
25,613.00
Goodwill
8,127.00
Other Intangible Assets
17,486.00
Other Investments
67.00
Non Current Deferred Assets
—
Non Current Deferred Taxes Assets
289.00
Other Non Current Assets
37.00
Total Liabilities Net Minority Interest
16,146.00
Current Liabilities
4,933.00
Payables And Accrued Expenses
—
Payables
3,683.00
Accounts Payable
2,058.00
Other Payable
1,313.00
Current Accrued Expenses
—
Employee Benefits
—
Total Tax Payable
312.00
Current Debt And Capital Lease Obligation
836.00
Current Debt
788.00
Other Current Borrowings
—
Current Capital Lease Obligation
48.00
Current Deferred Liabilities
—
Current Deferred Revenue
—
Other Current Liabilities
—
Total Non Current Liabilities Net Minority Interest
11,213.00
Long Term Debt And Capital Lease Obligation
7,748.00
Long Term Debt
7,663.00
Long Term Capital Lease Obligation
85.00
Long Term Provisions
40.00
Defined Pension Benefit
68.00
Non Current Pension And Other Postretirement Benefit Plans
114.00
Non Current Deferred Liabilities
—
Non Current Deferred Taxes Liabilities
3,222.00
Other Non Current Liabilities
30.00
Preferred Securities Outside Stock Equity
25.00
Stockholders Equity
16,425.00
Common Stock Equity
16,425.00
Capital Stock
90.00
Common Stock
90.00
Share Issued
8,952.35
Ordinary Shares Number
8,905.31
Treasury Shares Number
47.05
Additional Paid In Capital
2.00
Retained Earnings
27,847.00
Gains Losses Not Affecting Retained Earnings
—
Treasury Stock
156.00
Minority Interest
59.00
Other Equity Adjustments
—
Total Equity Gross Minority Interest
16,484.00
Total Capitalization
24,088.00
Working Capital
-383.00
Invested Capital
24,876.00
Total Debt
8,584.00
Net Debt
7,191.00
Capital Lease Obligations
133.00
Net Tangible Assets
-9,188.00
Tangible Book Value
-9,188.00
Available For Sale Securities
—
Current Provisions
69.00
Derivative Product Liabilities
34.00
Duefrom Related Parties Current
—
Dueto Related Parties Current
—
Financial Assets
9.00
Investmentin Financial Assets
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
2,634.00
+14.47%
2,301.00
+9.57%
2,100.00
+1.79%
2,063.00
Cash Flow From Continuing Operating Activities
—
—
—
—
Net Income From Continuing Operations
1,680.00
+13.90%
1,475.00
+32.76%
1,111.00
-0.71%
1,119.00
Depreciation Amortization Depletion
—
—
—
—
Depreciation
240.00
+6.67%
225.00
+11.94%
201.00
+11.67%
180.00
Amortization Cash Flow
120.00
+21.21%
99.00
-8.33%
108.00
+0.93%
107.00
Depreciation And Amortization
360.00
+11.11%
324.00
+4.85%
309.00
+7.67%
287.00
Amortization Of Intangibles
—
—
—
—
Other Non Cash Items
288.00
+0.35%
287.00
-19.61%
357.00
+65.28%
216.00
Pension And Employee Benefit Expense
-73.00
-7400.00%
1.00
-98.57%
70.00
+262.79%
-43.00
Stock Based Compensation
86.00
-15.69%
102.00
+34.21%
76.00
+406.67%
15.00
Asset Impairment Charge
—
—
—
—
Deferred Tax
472.00
+8.51%
435.00
-15.86%
517.00
+3.61%
499.00
Deferred Income Tax
—
—
—
—
Operating Gains Losses
—
—
—
—
Gain Loss On Investment Securities
-43.00
-16.22%
-37.00
—
—
Gain Loss On Sale Of PPE
0.00
+100.00%
-7.00
-158.33%
12.00
+140.00%
-30.00
Change In Working Capital
256.00
+24.27%
206.00
+292.52%
-107.00
-159.12%
181.00
Change In Receivables
-65.00
+79.17%
-312.00
-921.05%
38.00
+144.71%
-85.00
Changes In Account Receivables
—
—
—
—
Change In Inventory
133.00
-38.43%
216.00
+264.89%
-131.00
+55.14%
-292.00
Change In Payables And Accrued Expense
—
—
—
—
Change In Payable
125.00
-20.89%
158.00
+41.07%
112.00
-71.06%
387.00
Change In Account Payable
—
—
—
—
Change In Other Working Capital
—
—
—
—
Change In Other Current Assets
63.00
-56.25%
144.00
+214.29%
-126.00
-173.68%
171.00
Investing Cash Flow
-346.00
-165.53%
528.00
+494.03%
-134.00
+98.47%
-8,784.00
Cash Flow From Continuing Investing Activities
—
—
—
—
Net PPE Purchase And Sale
-322.00
-28.80%
-250.00
-6.84%
-234.00
+23.03%
-304.00
Purchase Of PPE
-322.00
-28.80%
-250.00
-6.84%
-234.00
+23.03%
-304.00
Sale Of PPE
—
—
0.00
0.00
Capital Expenditure
-413.00
-29.87%
-318.00
+5.36%
-336.00
-2.44%
-328.00
Net Investment Purchase And Sale
-6.00
0.00
0.00
-100.00%
700.00
Purchase Of Investment
-6.00
0.00
0.00
—
Sale Of Investment
—
0.00
0.00
-100.00%
700.00
Net Business Purchase And Sale
13.00
-97.09%
446.00
+728.17%
-71.00
0.00
Purchase Of Business
0.00
0.00
+100.00%
-71.00
0.00
Gain Loss On Sale Of Business
0.00
+100.00%
-121.00
0.00
0.00
Net Intangibles Purchase And Sale
-91.00
-135.41%
257.00
+78.47%
144.00
+1100.00%
12.00
Purchase Of Intangibles
-91.00
-33.82%
-68.00
+33.33%
-102.00
-325.00%
-24.00
Financing Cash Flow
-3,143.00
-104.49%
-1,537.00
+1.98%
-1,568.00
-122.69%
6,911.00
Cash Flow From Continuing Financing Activities
—
—
—
—
Net Issuance Payments Of Debt
-1,306.00
-300.31%
652.00
+217.90%
-553.00
-105.83%
9,486.00
Issuance Of Debt
46.00
-96.21%
1,214.00
0.00
-100.00%
11,004.00
Repayment Of Debt
-1,352.00
-140.57%
-562.00
-1.63%
-553.00
+63.57%
-1,518.00
Long Term Debt Issuance
46.00
-96.21%
1,214.00
0.00
-100.00%
11,004.00
Long Term Debt Payments
-1,352.00
-140.57%
-562.00
-1.63%
-553.00
+63.57%
-1,518.00
Net Long Term Debt Issuance
-1,306.00
-300.31%
652.00
+217.90%
-553.00
-105.83%
9,486.00
Net Common Stock Issuance
-654.00
-5.65%
-619.00
0.00
0.00
Common Stock Payments
-654.00
-5.65%
-619.00
0.00
0.00
Common Stock Dividend Paid
—
—
-388.00
+85.53%
-2,682.00
Cash Dividends Paid
-612.00
-7.37%
-570.00
-46.91%
-388.00
+85.53%
-2,682.00
Repurchase Of Capital Stock
-654.00
-5.65%
-619.00
0.00
0.00
Net Other Financing Charges
-143.00
+71.46%
-501.00
-355.45%
-110.00
-130.30%
363.00
Changes In Cash
-855.00
-166.18%
1,292.00
+224.62%
398.00
+109.47%
190.00
Effect Of Exchange Rate Changes
-49.00
+37.97%
-79.00
-426.67%
-15.00
-200.00%
15.00
Beginning Cash Position
2,207.00
+122.03%
994.00
+62.68%
611.00
+50.49%
406.00
End Cash Position
1,303.00
-40.96%
2,207.00
+122.03%
994.00
+62.68%
611.00
Free Cash Flow
2,221.00
+12.00%
1,983.00
+12.41%
1,764.00
+1.67%
1,735.00
Interest Paid CFF
-357.00
+0.83%
-360.00
+10.89%
-404.00
-147.85%
-163.00
Interest Received CFI
60.00
-20.00%
75.00
+177.78%
27.00
+42.11%
19.00
Sale Of Business
13.00
-97.09%
446.00
0.00
0.00
Sale Of Intangibles
0.00
-100.00%
325.00
+32.11%
246.00
+583.33%
36.00
Taxes Refund Paid
-439.00
+25.97%
-593.00
-33.26%
-445.00
-37.35%
-324.00
SEC Filings

No SEC filings found for this symbol (may be non-US or ticker not in SEC index).

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category